NewsBenzingaNuvation Bio To Present Updated Data From Its Phase 2 J201 Trial, Three Posters On Ongoing Studies Of Safusidenib At Society For Neuro-Oncology Annual Meeting Nuvation Bio To Present Updated Data From Its Phase 2 J201 Trial, Three Posters On Ongoing Studies Of Safusidenib At Society For Neuro-Oncology Annual Meeting Benzinga 2026.11.02 13:06 (GMT+0) Open on Benzinga Other news IBM Stock Moves Lower: What's Going On? JP Morgan Maintains Overweight on Itau Unibanco Holding, Lowers Price Target to $9 Amazon’s Big Week: First a New James Bond, Then Anthropic’s IPO JP Morgan Maintains Overweight on Allstate, Lowers Price Target to $291 TELUS Shares Rise After Québecor Submits Unsolicited Acquisition Proposal NVIDIA's Leadership Vacuum Hands AMD Its Biggest Opportunity in Years: Analysts